Interferon Alpha-2 : Pre-Clinical and Clinical Evaluation (Developments in Oncology)

Interferon alpha-2 is a genetically engineered, highly purified pharmaceutical agent that has undergone extensive phase I and phase II clinical study in more than 1000 patients.